Page 6 - Steven Pfanstiel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Marinus Pharma (MRNS) Enters $32 5M Revenue Interest Financing Agreement with Sagard Healthcare Partners

Marinus Pharma (MRNS) Enters $32 5M Revenue Interest Financing Agreement with Sagard Healthcare Partners
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Steven pfanstielRaja manchandaMarinus pharmaceuticals incHogan lovellsHc wainwright coMorgan stanley coSagard healthcare partnersChief financial officer

Novo strikes $110M deal for regulatory fast pass

BioPharma

Bridgebio pharmaSteven pfanstielMarinus pharmaceuticalsDrug administrationNovo nordiskPennsylvania based marinus pharmaceuticalsBiomarin pharmaceuticalFinancial officer steven pfanstiel

Marinus Pharmaceuticals Sells Rare Pediatric Disease Priority Review Voucher for $110 Million

RADNOR, Pa. (BUSINESS WIRE) $MRNS #MarinusPharma Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced that it has entered into a definitive agreement to sell its Rare Pediatric Disease Priority Re.

Steven pfanstielSasha damouni ellisCompany contactCorporate affairs investor relationsDrug administrationMarinuspharma marinus pharmaceuticals incMarinus pharmaceuticalsExchange commissionMarinus pharmaceuticals incMarinuspharma marinus pharmaceuticalsRare pediatric disease priority review voucherChief financial officerNew drug applicationBiologics licensePrivate securities litigation reform actCorporate affairs

Marinus Pharma Shares Up After Deal for Rare Pediatric Disease Priority Review Voucher

Marinus Pharma Shares Up After Deal for Rare Pediatric Disease Priority Review Voucher
morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.

Steven pfanstielMichael dabaieExchange commissionMarinus pharmaceuticals incDow jones company incDrug administrationNovo nordisk incRare pediatric disease priority review voucherNovo nordiskMarinus chief financial officer steven pfanstielDow jones

Marinus Sells Rare Pediatric Disease Priority Review Voucher to Novo Nordisk for $110 Million

Marinus Sells Rare Pediatric Disease Priority Review Voucher to Novo Nordisk for $110 Million
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

Steven pfanstielMarinus pharmaceuticalsDrug administrationNovo nordiskRare pediatric disease priority review voucherPediatric disease priority reviewNew drug applicationBiologics license